We move you through the stages of re-trusting your hunger, re-patterning your reward centers, and ultimately, shifting your identity into the woman who just eats effortlessly
The 0.25 mg dose is an initial titration dose designed to improve tolerability, not for glycaemic control, and elimination time is identical across all doses
The severity of OSA is quantified using the apnea-hypopnea index (AHI), which measures the number of breathing interruptions per hour of sleep
Your body has a complex signaling system that regulates hunger, blood sugar, fat storage, and energy expenditure
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for weight management (in conjunction with a reduced calorie diet and exercise) in adults with obesity or who are overweight with at least one weight-related medical condition (such as high blood pressure, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease)